The European Falsified Medicines Directive (FMD)
To fight counterfeit medication, the European Union (EU) adopted the Falsified Medicine Directive (FMD), effective as of February 9th, 2019. The directive, referred to as 2016/161/EU, has been in place for quite some time since first being published on February 9th, 2016. Now, we will focus on the two outlying countries that use their own systems and have not implemented FMD: Italy and Greece. These countries are still navigating their compliance journey until 2025. To make this transition, Italy must move from pre-existing labels, like Bollino, to GS1 standards, and Greece must move existing label infrastructure and processes to the FMD Unique Identifier (UI) to properly manage data migration for shared packs.
Whitepapers
